Bigul

Sanofi India Ltd - 500674 - Unaudited Financial Results For The Quarter Ended 31St March 2020

We refer to our letter dated 12th May 2020 informing you of our Board Meeting that was scheduled today. The Meeting of Board of Directors commenced at 11.30 a.m. and concluded at 1.40 p.m. The Board approved unaudited financial results for the quarter ended 31st March 2020. Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose a copy of the unaudited financial results for the quarter ended 31st March 2020 approved at this Meeting along with a copy of the Limited Review Report for your information.
20-05-2020

Sanofi India Q1 net profit declines 8% to Rs 85.4 crore

Revenue from operations of the company stood at Rs 784.5 crore for the quarter under consideration. It was Rs 717.3 crore for the same period a year ago, it added.
19-05-2020
Bigul

Sanofi India Ltd - 500674 - Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended 31St March 2020

Pursuant to Regulation 40 (9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith Certificate of M/s. Makarand M. Joshi & Co., Company Secretaries for the half year ended 31st March 2020.
19-05-2020
Bigul

Sanofi India Ltd - 500674 - Outcome Of Board Meeting - Annual General Meeting (AGM), Book Closure And Dividend Payment Date

Please find attached announcement related to Annual General Meeting (AGM), Book Closure and Dividend Payment Date
19-05-2020
Bigul

Sanofi India Ltd - 500674 - Unaudited Financial Results For The Quarter Ended 31St March 2020

We refer to our letter dated 12th May 2020 informing you of our Board Meeting that was scheduled today. The Meeting of Board of Directors commenced at 11.30 a.m. and concluded at 1.40 p.m. The Board approved unaudited financial results for the quarter ended 31st March 2020. Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose a copy of the unaudited financial results for the quarter ended 31st March 2020 approved at this Meeting along with a copy of the Limited Review Report for your information. Please take the above information on record.
19-05-2020

Sanofi says COVID-19 vaccine will be available worldwide simultaneously

"There will be no particular advance given to any country," Serge Weinberg told France 2 television.
15-05-2020
Bigul

Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Please find enclosed copies of the Notice of the Board Meeting of the Company published today, in newspapers, Business Standard and Sakal.
13-05-2020
Bigul

Sanofi India Ltd - 500674 - Board Meeting Intimation for Meeting Of Board Of Directors To Be Held On 19Th May 2020

Sanofi India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2020 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the meeting of the Board of Directors of the Company will be held on Tuesday, 19th May 2020; inter alia to consider the unaudited financial results for the quarter ended 31st March 2020 (Q1).
12-05-2020

Sanofi to enroll thousands for its coronavirus vaccine trials

Sanofi is working on two vaccine projects to prevent COVID-19 - the illness caused by the new coronavirus - and said it is exploring several manufacturing options
06-05-2020
Bigul

Sanofi India Ltd - 500674 - Compliance Certificate - Regulation 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Pursuant to Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the compliance certificate for the period 1st October 2019 to 31st March 2020.
05-05-2020
Next Page
Close

Let's Open Free Demat Account